Negative depletion of CD3+ and TcRαβ+T cells

Current Opinion in Hematology

Volumn 19, Issue 6, 2012, Pages 434-439

  Handgretinger, Rupert ^a  

^a Children's Hospital   (Germany)

Author keywords

allogeneic transplantation; peripheral stem cells; T cell depletion

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; CD34 ANTIGEN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ACUTE GRAFT VERSUS HOST DISEASE; ANTINEOPLASTIC ACTIVITY; BIOMEDICAL ENGINEERING; BONE MARROW; CANCER SURVIVAL; CELL SELECTION; EVENT FREE SURVIVAL; EX VIVO STUDY; HUMAN; NATURAL KILLER T CELL; PERIPHERAL BLOOD STEM CELL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; T CELL DEPLETION; T LYMPHOCYTE;

ANTIGENS, CD3; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOCYTE DEPLETION; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 84868207569     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e3283582340     Document Type: Review

References (34)

1. Champlin RE, Passweg JR, Zhang MJ, et al. T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities. Blood 2000; 95:3996-4003.
2. Schumm M, Lang P, Taylor G, et al. Isolation of highly purified autologous and allogeneic peripheral CD34+ cells using the CliniMACS device. J Hematother 1999; 8:209-218.
3. Reisner Y, Kapoor N, Kirkpatrick D, et al. Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood 1983; 61:341-348.
4. Friedrich W, Goldmann SF, Vetter U, et al. Immunoreconstitution in severe combined immunodeficiency after transplantation of HLA-haploidentical, T-cell-depleted bone marrow. Lancet 1984; 1:761-764.
5. Kernan NA, Flomenberg N, Dupont B, O'Reilly RJ. Graft rejection in recipients of T-cell-depleted HLA-nonidentical marrow transplants for leukemia. Identification of host-derived antidonor allocytotoxic T lymphocytes. Transplantation 1987; 43:842-847.
6. Mehta J, Singhal S, Gee AP, et al. Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: single-center experience of 201 patients. Bone Marrow Transplant 2004; 33:389-396.
7. Hongeng S, Krance RA, Bowman LC, et al. Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukaemia. Lancet 1997; 350:767-771.
8. Rachamim N, Gan J, Segall H, et al. Tolerance induction by 'megadose' hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host antidonor cytotoxic T lymphocyte precursors in mixed lymphocyte culture. Transplantation 1998; 65:1386-1393.
9. Berenson RJ, Shpall EJ, Auditore-Hargreaves K, et al. Transplantation of CD34+ hematopoietic progenitor cells. Cancer Invest 1996; 14:589-596.
10. Handgretinger R, Lang P, Schumm M, et al. Isolation and transplantation of autologous peripheral CD34+ progenitor cells highly purified by magneticactivated cell sorting. Bone Marrow Transplant 1998; 21:987-993.
11. Ruggeri L, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002; 295:2097-2100.
12. Gordon PR, Leimig T, Mueller I, et al. A large-scale method for T cell depletion: towards graft engineering of mobilized peripheral blood stem cells. Bone Marrow Transplant 2002; 30:69-74.
13. Barfield RC, Otto M, Houston J, et al. A one-step large-scale method for T-and B-cell depletion of mobilized PBSC for allogeneic transplantation. Cytotherapy 2004; 6:1-6.
14. Hale GA, Kasow KA, Gan K, et al. Haploidentical stem cell transplantation with CD3 depleted mobilized peripheral blood stem cell grafts for children with hematologic malignancies [abstract]. Blood (ASH Annual Meeting Abstracts) 2005; 106:abstr. 2910.
15. Hale GA, Kasow KA, Madden R, et al. Mismatched family member donor transplantation for patients with refractory hematologic malignancies: longterm followup of a prospective clinical trial [abstract]. Blood (ASH Annual Meeting Abstracts) 2006; 108:abstr. 3137.
16. Chen X, Hale GA, Barfield R, et al. Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies. Br J Haematol 2006; 135:524-532.
17. Dykes JH, Toporski J, Juliusson G, et al. Rapid and effective CD3 T-cell depletion with a magnetic cell sorting program to produce peripheral blood progenitor cell products for haploidentical transplantation in children and adults. Transfusion 2007; 47:2134-2142.
18. Handgretinger R, Chen X, Pfeiffer M, et al. Feasibility and outcome of reduced-intensity conditioning in haploidentical transplantation. Ann N Y Acad Sci 2007; 1106:279-289.
19. Lang P, Mueller I, Greil J, et al. Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patients. Blood Cells Mol Dis 2008; 40:33-39.
20. Pfeiffer MM, Feuchtinger T, Teltschik HM, et al. Reconstitution of natural killer cell receptors influences natural killer activity and relapse rate after haploidentical transplantation of T-and B-cell depleted grafts in children. Haematologica 2010; 95:1381-1388.
21. Bader P, Soerensen J, Jarisch A, et al. Rapid immune recovery and low TRM in haploidentical stemcell transplantation in children andadolescence usingCD3/CD19-depleted stemcells. Best Pract Res Clin Haematol 2011; 24:331-337.
22. Dufort G, Pisano S, Incoronato A, et al. Feasibility and outcome of haploidentical SCT in pediatric high-risk hematologic malignancies and Fanconi anemia in Uruguay. Bone Marrow Transplant 2012; 47:663-668.
23. Palma J, Salas L, Carrion F, et al. Haploidentical stem cell transplantation for children with high-risk leukemia. Pediatr Blood Cancer 2012. [Epub ahead of print]
24. Perez-Martinez A, Gonzalez-Vicent M, Valentin J, et al. Early evaluation of immune reconstitution following allogeneic CD3/CD19-depleted grafts from alternative donors in childhood acute leukemia. Bone Marrow Transplant 2012. [Epub ahead of print]
25. Leung W, Campana D, Yang J, et al. High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia. Blood 2011; 118:223-230.
26. Eissens DN, Schaap NP, Preijers FW, et al. CD3 +CD19+-depleted grafts in HLA-matched allogeneic peripheral blood stem cell transplantation lead to early NK cell cytolytic responses and reduced inhibitory activity of NKG2A. Leukemia 2010; 24:583-591.
27. Federmann B, Bornhauser M, Meisner C, et al. Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II study. Haematologica 2012. [Epub ahead of print]
28. Chaleff S, Otto M, Barfield RC, et al. A large-scale method for the selective depletion of alphabeta T lymphocytes from PBSC for allogeneic transplantation. Cytotherapy 2007; 9:746-754.
29. Bonneville M, O'Brien RL, Born WK. Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity. Nat Rev Immunol 2010; 10:467-478.
30. Chiplunkar S, Dhar S, Wesch D, Kabelitz D. gammadelta T cells in cancer immunotherapy: current status and future prospects. Immunotherapy 2009; 1:663-678.
31. Handgretinger R, Lang P, Feuchtinger TF, et al. Transplantation of TcR{alpha}{ beta}/CD19 depleted stem cells from haploidentical donors: robust engraftment and rapid immune reconstitution in children with high risk leukaemia [abstract]. Blood (ASH Annual Meeting Abstracts) 2011; 118: abstr. 1005.
32. Godder KT, Henslee-Downey PJ, Mehta J, et al. Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation. Bone Marrow Transplant 2007; 39:751-757.
33. Federmann B, Hagele M, Pfeiffer M, et al. Immune reconstitution after haploidentical hematopoietic cell transplantation: impact of reduced intensity conditioning and CD3/CD19 depleted grafts. Leukemia 2011; 25:121-129.
34. Chen X, Barfield R, Benaim E, et al. Prediction of T-cell reconstitution by assessment of T-cell receptor excision circle before allogeneic hematopoietic stem cell transplantation in pediatric patients. Blood 2005; 105:886-893.